Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aerva lanata, commonly known as Mountain Knotgrass or Polpala, is a medicinal plant widely used in traditional African and Ayurvedic medicine for the management of diabetes mellitus and urinary tract disorders. Pharmacological research indicates that extracts from its leaves, particularly hydroethanolic preparations, contain a high concentration of phenolic compounds that act as uncompetitive inhibitors of alpha-amylase and alpha-glucosidase. By inhibiting these key enzymes involved in carbohydrate metabolism, Aerva lanata helps to mitigate postprandial hyperglycemia. Furthermore, the plant exhibits significant antioxidant activity through free radical scavenging, which may provide protective effects against oxidative stress associated with chronic metabolic conditions. It is also traditionally employed as a lithontriptic agent to dissolve kidney stones and as a diuretic for treating urinary tract infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aerva lanata.